Menzel, A.; Samouda, H.; Dohet, F.; Loap, S.; Ellulu, M.S.; Bohn, T.
Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”. Antioxidants 2021, 10, 865.
https://doi.org/10.3390/antiox10060865
AMA Style
Menzel A, Samouda H, Dohet F, Loap S, Ellulu MS, Bohn T.
Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”. Antioxidants. 2021; 10(6):865.
https://doi.org/10.3390/antiox10060865
Chicago/Turabian Style
Menzel, Alain, Hanen Samouda, Francois Dohet, Suva Loap, Mohammed S. Ellulu, and Torsten Bohn.
2021. "Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”" Antioxidants 10, no. 6: 865.
https://doi.org/10.3390/antiox10060865
APA Style
Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T.
(2021). Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”. Antioxidants, 10(6), 865.
https://doi.org/10.3390/antiox10060865
